Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas

American Journal of Surgical Pathology

Volumn 24, Issue 2, 2000, Pages 211-222

  Miettinen, Markku ^a   Sarlomo Rikala, Maarit ^b   Sobin, Leslie H ^a   Lasota, Jerzy ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NONE

Author keywords

C kit; Gastrointestinal stromal tumor; Genetics; GIST; Immunhistochemistry; Leiomyoma; Leiomyosarcoma; Pathology

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; DESMIN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGUS TUMOR; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MITOSIS INDEX; ONCOGENE C KIT; TUMOR LOCALIZATION;

AGED; AMINO ACID SEQUENCE; ANTIGENS, CD34; BASE SEQUENCE; DIAGNOSIS, DIFFERENTIAL; DNA PRIMERS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033974638     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200002000-00007     Document Type: Article

References (39)

1. Appelman HD. Mesenchymal tumors of the gut: histological perspectives, new approaches, new results, and does it make any difference. Monogr Pathol 1990;31:220-46.
2. Appelman HD, Helwig EB. Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 1977;101:373-7.
3. Appelman HD, Helwig EB. Sarcomas of the stomach. Am J Clin Pathol 1977;67:2-10.
4. Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol 1988;19:257-64.
5. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Am J Surg Pathol 1999;23:82-7.
6. Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastr Pathol 1996;20: 373-93.
7. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998;78:1633-6.
8. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995;103:41-7.
9. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-80.
10. Johanet H, Marmuse JP, Timores A. et al. Leiomyosarcoma of the esophagus 8 years after the diagnosis of a leiomyoma [Abstract]. Gastroenterol Clin Biol 1991;15:780.
11. Kindblom LG, Remotti HE. Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
12. Kitamura Y, Hirota S, Nishida T. Molecular pathology of c-kit proto-oncogen and development of gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:282-6.
13. Kramer MD, Gibb PS, Ellis FH. Giant leiomyoma of esophagus. J Surg Oncol 1986;33:166-9.
14. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. c-kit Mutations occur preferentially in malignant vs. benign gastrointestinal stromal tumors and do not occur in leiomyomas and leiomyosar-comas predominantly in malignant GISTs. Am J Pathol 1999;154: 53-60.
15. Lecoin L. Gabella G. Le Douarin N. Origin of the c-kit positive interstitial cells in the avian bowel. Development 1996;122:725-33.
16. Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology. Washington. DC: AFIP, 1996.
17. Maeda H, Yamagata A, Nishikawa S, et al. Requirement of c-kit for development of intestinal pacemaker system. Development 1992;116:369-75.
18. Mazur MT, Clark HB. Gastric stromal stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-19.
19. Miettinen M. Gastrointestinal stromal tumors. An immunohistochemical study of cellular differentiation. Am J Clin Pathol 1988; 89:601-10.
20. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors in the omentum and mesentery - clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999;23:1109-18.
21. Miettinen M. Virolainen M. Sarlomo-Rikala M. Gastrointestinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 1995;19:207-16.
22. Mikhael AI, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. CD34-expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem 1994;2:89-93.
23. Min K-W. Small intestinal stromal tumors with skeinoid fibers. Clinicopathological. immunohistochemical, and ultrastructural investigations. Am J Surg Pathol 1992;16:145-55.
24. Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology 1994;25:469-73.
25. Moskaluk CA, Tian Q, Marshall CR, Rumpel CA, Franquemont DW, Frierson HF. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 1999;18:1897-902.
26. Nakahara M, Isozaki K, Hirota S, et al. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 1998;115:1090-5.
27. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 1998;19:323-5.
28. Ranchod M, Kempson RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. Cancer 1977;39:255-62.
29. Sanders KM. A case for interstitial cells as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996;111:492-515.
30. Sarlomo-Rikala M, El-Rifai W, Andersson L, Miettinen M, Knuutila S. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas and schwannomas. Hum Pathol 1998;29:476-81.
31. Sarlomo-Rikala M, Kovatich A, Barusevicius A. Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-34.
32. Sarlomo-Rikala M, Miettinen M. Gastric schwannoma. Clinicopathologic analysis of six cases. Histopathology 1995;27:335-40.
33. Seremetis MG, Lyons WS, deGuzman VC, Peabody JW. Leiomyomata of the esophagus. An analysis of 838 cases. Cancer 1976;38:2166-77.
34. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors for gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377-89.
35. Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996;13:297-313.
36. Ueyama T, Guo K-J, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947-55.
37. van de Rijn M, Rouse RV. CD 34. A review. Appl Immunohistochem 1994;2:71-80.
38. Vliagoftis H, Worobec AS, Metcalfe DD. The proto-oncogene c-kit and c-kit ligand in human disease. J Allerg Clin Immunol 1997; 100:435-40.
39. Young HM, Ciampoli D, Southwell BR, Newgreen DF. Origin of interstitial cells of Cajal in the mouse intestine. Dev Biol 1996; 180:97-107.